ADM vs INGR: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

ADM is the larger of the two ($33.06B market cap): the incumbent the market prices for continued execution (12.29x forward earnings, beta 0.62). INGR is the smaller challenger ($5.66B), cheaper on forward earnings (8.82x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

ADM vs INGR: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricADMINGRWhat it tells you
Market cap$33.06B$5.66BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E12.298.82Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E13.5710.31Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.620.62Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range41% of range2% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book1.391.24How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: INGR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how ADM and INGR affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ADM and INGR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ADM and INGR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Archer-Daniels-Midland (ADM) do?

Archer-Daniels-Midland is a global agribusiness that sources, transports, stores, processes, and merchandises agricultural commodities and ingredients. It runs three reportable segments: Ag Services and Oilseeds (the largest, spanning grain origination, oilseed crushing, and global trading), Carbohydrate Solutions (corn wet milling, sweeteners, starches, and ethanol), and Nutrition (human and animal ingredients, flavors, and specialty products). Along with Bunge, Cargill, and Louis Dreyfus it is one of the "ABCD" firms that move a large share of the world's grain and oilseeds, making it a core piece of the food and biofuel supply chain.

Full ADM guide

What does Ingredion Incorporated (INGR) do?

Ingredion Incorporated grinds corn and other crops into starches, sweeteners and texturizing ingredients that end up inside packaged food, beverages, paper and pharmaceuticals. The business reports in three segments: Texture & Healthful Solutions, the global specialty texturant arm that produced ~$627 million of second quarter net sales; Food and Industrial Ingredients in Latin America, at ~$611 million; and Food and Industrial Ingredients in the US and Canada, at ~$488 million. A fourth bucket called All Other holds the PureCircle stevia, sugar reduction and pea protein fortification businesses. Trailing twelve month revenue runs about ~$7.2 billion on a market capitalisation near ~$6.2 billion as of October 2026, and the company has been reshaping the portfolio hard, closing its Cabo plant in Brazil and selling ~51% of its Pakistan subsidiary for ~$165 million in June 2026.

Full INGR guide

ADM vs INGR: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • ADM drivers: Crush and ethanol margin recovery; US biofuel and renewable-diesel policy.
  • INGR drivers: Corn costs pass through, so revenue and profit move separately; Texture & Healthful Solutions carries the mix shift.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: ADM is highly cyclical and its profits depend on crush margins, ethanol spreads, and crop supply that it cannot control, so earnings can drop sharply in a bad year as 2025 showed. For INGR, the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date.

ADM or INGR: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ADM if you believe its drivers more; INGR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ADM and INGR guides.

ADM vs INGR: the full fundamentals

ADM. At $82.94, ADM trades near 23x trailing GAAP earnings, which still include the weak 2025 quarters, and about 15x forward estimates that assume 2026's recovered margins persist. The roughly 2.5% dividend yield and 53-year raise streak remain a large part of the total-return case. The third-quarter report on November 3, 2026 (consensus EPS about $1.59 on $23.5 billion of revenue) will show whether the crush rebound carried through the summer.

INGR. Near ~$98.50 a share on October 16, 2026 the stock carries about ~10.7 times trailing earnings, roughly ~9.4 times the midpoint of 2026 adjusted guidance and ~8.8 times next year's consensus, a visible discount to the branded specialty ingredient houses. That gap prices the commodity half of the business, the Argo disruption and the leverage still to arrive; the six covering analysts sit at hold with a mean target near ~$119.50. Reported and adjusted earnings diverge unusually far this year because of the Cabo closure charges, the ~$44 million Pakistan disposal gain and the acquisition hedges, so the ~$9.15 to ~$9.75 reported guide sits well below the ~$10.30 to ~$10.90 adjusted one.

Headline figures (approximate, October 2026): ADM shows revenue (ttm) ~$82B (+7% YoY latest qtr), net income (ttm) ~$1.8B (2.2% margin), q2 2026 adjusted eps ~$1.84 (vs ~$0.93 a year earlier), 2026 adjusted eps guidance ~$5.15 to $5.60; INGR shows market cap ~$6.2B, revenue (ttm) ~$7.2B (Q2 up ~1% YoY), net income (ttm) ~$592M (EPS ~$9.20), margins (gross / operating) ~23.7% / ~12.6%.

The bottom line: ADM vs INGR

ADM and INGR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ADM and INGR exposure against your real portfolio. It is not an investment adviser.

Wondering how ADM or INGR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Archer-Daniels-Midland

Ask Walnut's AI anything about ADM and see how it fits what you own.

FAQ

What is the difference between ADM and INGR?

+

Archer-Daniels-Midland is a global agribusiness that sources, transports, stores, processes, and merchandises agricultural commodities and ingredients. Ingredion Incorporated grinds corn and other crops into starches, sweeteners and texturizing ingredients that end up inside packaged food, beverages, paper and pharmaceuticals. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ADM or INGR the better stock?

+

Neither is universally better. ADM is the larger incumbent; INGR is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ADM or INGR?

+

On forward P/E (as of November 2026), ADM trades at 12.29x and INGR at 8.82x, so INGR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ADM and INGR?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ADM vs INGR?

+

ADM: ADM is highly cyclical and its profits depend on crush margins, ethanol spreads, and crop supply that it cannot control, so earnings can drop sharply in a bad year as 2025 showed. The 2026 recovery raises the bar: analysts expect 2027 EPS of about $5.67, only slightly above 2026, and the stock trades above the average analyst price target of roughly $80, so any fading of margins could hit the shares. Recent commentary points to weakness in sweeteners and a 22% earnings drop at Wilmar, an Asian agribusiness in which ADM holds a stake. The company settled an SEC accounting matter tied to how intersegment sales inflated Nutrition results in 2021 and 2022, paying a $40 million civil penalty (with the DOJ closing its criminal probe without charges), which has left a governance and credibility overhang. Trade policy, tariffs, and shifting global grain flows can disrupt origination and trading economics. Finally, a low-margin commodity business model means thin percentage margins on very large revenue (about a 2% net margin), so small swings in input costs or realized prices have outsized effects on the bottom line. INGR: The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Funding Tate & Lyle takes net debt from roughly ~$0.8 billion today to about ~3.0x EBITDA at completion, and with closing not expected until the second half of 2027 there is a long window of antitrust review, integration planning and carrying cost before any synergy shows up. Second quarter financing costs jumped to ~$55 million mostly because of ~$47 million in hedging losses on the sterling consideration, so the currency exposure is already live even though the deal is not. Latin America supplies roughly a third of sales and carries Mexican peso translation risk plus what management called a more challenging demand environment. High fructose corn syrup consumption in North America is in slow secular decline, which the specialty growth has to outrun rather than merely offset. Analysts expect 2026 adjusted EPS of about ~$10.50, down ~6% on 2025, before a ~7% rebound to ~$11.25 in 2027, so the recovery case rests on the second half of this year.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ADM or INGR; figures are approximate and dated (as of November 2026). Verify current data before investing.